Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FREEHILL MINING LIMITED. Capital/Financing Update 2020

Jan 20, 2020

64918_rns_2020-01-20_ae6303e2-1ed8-4c5e-b3c1-68f02dfbc05d.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

FREEHILL MINING LIMITED

ABN

27 091 608 025

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

  • 1 +Class of +securities issued or to Fully paid ordinary shares. be issued

  • 2 Number of[+] securities issued or 30,727,271 to be issued (if known) or maximum number which may be issued

  • 3 Principal terms of the[+] securities Fully paid ordinary shares on the same (e.g. if options, exercise price and terms as the existing fully paid ordinary expiry date; if partly paid shares on issue. +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

4 Do the[+] securities rank equally in Yes, the shares rank equally with existing all respects from the[+] issue date ordinary shares. with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state:  the date from which they do  the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration Shares issued at a price of $0.011 per Share. 6 Purpose of the issue Shares issued to sophisticated and (If issued as consideration for professional investors on conversion of the acquisition of assets, clearly principal of loan amount pursuant to a loan identify those assets) agreement. 6a Is the entity an[+] eligible entity Yes. that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the[+] securities the subject of this Appendix 3B , and comply with section 6i 6b The date the security holder 29 November 2019 resolution under rule 7.1A was passed 6c Number of +securities issued 30,727,271 without security holder approval under rule 7.1 6d Number of +securities issued Nil. with security holder approval under rule 7.1A 6e Number of +securities issued Nil. with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

  • See chapter 19 for defined terms.

Appendix 3B Page 2

04/03/2013

6f
Number of
+securities issued
under an exception in rule 7.2
6g
If+securities issued under rule
7.1A, was issue price at least
75%
of
15
day
VWAP as
calculated under rule 7.1A.3?
Include the+issue date and both
values. Include the source of the
VWAP calculation.
6h
If+securities were issued under
rule
7.1A
for
non-cash
consideration,
state
date
on
which valuation of consideration
was released to ASX Market
Announcements
6i
Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
7
+Issue dates
Note: The issue date may be prescribed by ASX
(refer to the definition of issue date in rule
19.12). For example, the issue date for a pro
rata entitlement issue must comply with the
applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
Nil.

N/A
N/A
7.1 Capacity: 71,761,601
7.1A Capacity: 116,711,890
21 January 2020
8
Number
and
+class
of
all
+securities
quoted
on
ASX
(including
the
+securities
in
section 2 if applicable)
Number +Class
1,265,065,135
176,481,084
Fully Paid Ordinary
Shares
Options to acquire
one
fully
paid
ordinary share each,
exercisable
at
$0.025, expiring on
12November 2021.
9
Number
and
+class
of
all
+securities not quoted on ASX
(including
the
+securities
in
section 2 if applicable)
10
Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
Number +Class
1,000,000 Performance
rights
issued on 6 February
2017 to the Company
COO.
1,984,725 Options exercisable
at $0.1425 vesting 16
May 2018 and
expiring on 16 May
2023.
10,000,000 Options to acquire
one fully paid
ordinary share each,
exercisable at
$0.025, expiring on
12November 2021.
30,000,000 Options exercisable
at $0.10 vesting 12
November 2019 and
expiring on 12
November 2022.
The Board of the Company may from time to
time determine to distribute the profits of
the Company by way of dividend amongst
the Shareholders in proportion to the
amounts paid up onthe Sharesheld by them.
  • See chapter 19 for defined terms.

Appendix 3B Page 4

04/03/2013

Part 2 - Pro rata issue

art 2 - Pro rata issue
11
Is
security
holder
approval
required?
12
Is the issue renounceable or non-
renounceable?
13
Ratio in which the+securities will
be offered
14
+Class of+securities to which the
offer relates
15
+Record
date
to
determine
entitlements
16
Will
holdings
on
different
registers (or subregisters) be
aggregated
for
calculating
entitlements?
17
Policy for deciding entitlements in
relation to fractions
18
Names of countries in which the
entity has security holders who
will not be sent new offer
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing
date
for
receipt
of
acceptances or renunciations
20
Names of any underwriters
21
Amount of any underwriting fee
or commission
22
Names of any brokers to the issue
23
Fee or commission payable to the
broker to the issue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
24
Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
25
If the issue is contingent on
security holders’ approval, the
date of the meeting
26
Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
27
If the entity has issued options,
and the terms entitle option
holders to participate on exercise,
the date on which notices will be
sent to option holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do security holders sell their
entitlements_in full_through a
broker?
31
How do security holders sell_part_
of their entitlements through a
broker
and
accept
for
the
balance?
32
How do security holders dispose
of their entitlements (except by
sale through a broker)?
33
+Issue date
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 6

04/03/2013

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of[+] securities ( tick one )

  • (a) +Securities described in Part 1

  • (b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

38 Number of[+] securities for which +quotation is sought

39 +Class of +securities for which quotation is sought

40 Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state:  the date from which they do  the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another[+] security, clearly identify that other[+] security)

Number +Class 42 Number and +class of all +securities quoted on ASX ( including the[+] securities in clause 38)

  • See chapter 19 for defined terms.

Appendix 3B Page 8

04/03/2013

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ........................................................... Date: 21 January 2020 Print name: Paul Davies == == == == ==

  • See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 9

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

Part 1 Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insertnumber of fully paid+ordinary
securities on issue 12 months before the
+issue date or date of agreement to issue
648,568,352
Addthe following:
• Number of fully paid+ordinary securities
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid+ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid+ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
7,147,058 fully paid ordinary shares (Issued
28 February 2019, Rule 7.2, Exception 4)
3,200,000 fully paid ordinary shares (Issued
28 February 2019, Rule 7.2, Exception 3)
3,967,476 fully paid ordinary shares (Issued
4 March 2019, Rule 7.2, Exception 4)
18,181,731 fully paid ordinary shares (Issued
6 March 2019, Rule 7.2, Exception 4)
20,571,122 fully paid ordinary shares (Issued
8 March 2019, Rule 7.4)
75,686,570 fully paid ordinary shares (Issued
8 March 2019, Rule 7.2, Exception 4)
19,093,800 fully paid ordinary shares (Issued
12 March 2019, Rule 7.2, Exception 4)
8,333,334 fully paid ordinary shares (Issued
12 March 2019, Rule 7.4)
6,000,000 fully paid ordinary shares (Issued
16 April 2019, Rule 7.4)
5,494,506 fully paid ordinary shares (Issued
17 May 2019, Rule 7.2, Exception 4)
287,600,412 fully paid ordinary shares
(Issued 12 November 2019, Rule 7.3)
2,142,613 fully paid ordinary shares (Issued
12 November 2019, Rule 7.2, Exception 4)
  • See chapter 19 for defined terms.

Appendix 3B Page 10

04/03/2013

34,057,148 fully paid ordinary shares (Issued
14 November 2019, Rule 7.2, Exception 4)
2,572,457 fully paid ordinary shares (Issued
29 November 2019, Rule 7.2, Exception 14)
19,999,997 fully paid ordinary shares (Issued
20 December 2019, Rule 7.3)
4,502,324 fully paid ordinary shares (Issued
20 December 2019, Rule 7.2, Exception 4)
Subtractthe number of fully paid+ordinary
securities cancelled during that 12 month
period
Nil.
“A” 1,167,118,900

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A” Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 175,067,835
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period_not counting_those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
30,000 fully paid ordinary shares (8 March
2019)
5,360,000 options exercisable at $0.025 per
option, expiring 12 November 2021 (12
November 2019)
44,925,325 fully paid ordinary shares (12
November 2019)
3,000,000 fully paid ordinary shares (3
December 2019)
19,263,638 fully paid ordinary shares (3
January 2020)
30,727,271 fully paid ordinary shares (21
January 2020)
“C” 103,306,234
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
Step 2: Calculate 15% of “A” Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 175,067,835
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period_not counting_those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
30,000 fully paid ordinary shares (8 March
2019)
5,360,000 options exercisable at $0.025 per
option, expiring 12 November 2021 (12
November 2019)
44,925,325 fully paid ordinary shares (12
November 2019)
3,000,000 fully paid ordinary shares (3
December 2019)
19,263,638 fully paid ordinary shares (3
January 2020)
30,727,271 fully paid ordinary shares (21
January 2020)
“C” 103,306,234
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
  • See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 11

“A” x 0.15
Note: number must be same as shown in
Step 2
175,067,835
Subtract“C”
Note: number must be same as shown in
Step 3
103,306,234
Total[“A” x 0.15] – “C” 71,761,601
[Note: this is the remaining placement
capacity under rule 7.1]
  • See chapter 19 for defined terms.

Appendix 3B Page 12

04/03/2013

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Part 2 Part 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A”
Note: number must be same as shown in
Step 1 of Part 1
1,167,118,900
Step 2: Calculate 10% of “A”
“D” 0.10
Note: this value cannot be changed
Multiply“A” by 0.10 116,711,890
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
Nil.
“E” 0
  • See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 13

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
116,711,890
Subtract“E”
Note: number must be same as shown in
Step 3
0
Total[“A” x 0.10] – “E” 116,711,890
Note: this is the remaining placement
capacity under rule 7.1A
  • See chapter 19 for defined terms.

Appendix 3B Page 14

04/03/2013